ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday

ENDRA Life Sciences (NASDAQ:NDRAGet Free Report) is projected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect ENDRA Life Sciences to post earnings of ($4.10) per share for the quarter.

ENDRA Life Sciences Stock Up 0.8 %

Shares of NASDAQ NDRA opened at $4.04 on Thursday. The firm’s 50-day moving average price is $4.85 and its two-hundred day moving average price is $6.32. ENDRA Life Sciences has a 52-week low of $3.15 and a 52-week high of $1,872.50. The stock has a market capitalization of $2.17 million, a P/E ratio of 0.00 and a beta of 0.43.

ENDRA Life Sciences Company Profile

(Get Free Report)

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Recommended Stories

Earnings History for ENDRA Life Sciences (NASDAQ:NDRA)

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.